| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | 0.063 | 0.07 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.084 | 0.07 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.07 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.064 | 0.07 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.07 |
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | 0.054 | 0.08 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.08 |
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.08 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | -0.063 | 0.08 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | -0.12 | 0.08 |